ABCA2 |
ATP binding cassette subfamily A member 2 |
- ABC transporters in lipid homeostasis
|
|
|
ADGRB1 |
adhesion G protein-coupled receptor B1 |
|
|
|
ADGRG1 |
adhesion G protein-coupled receptor G1 |
|
|
|
ADORA2A |
adenosine A2a receptor |
- NGF-independant TRKA activation
- Adenosine P1 receptors
- G alpha (s) signalling events
- Surfactant metabolism
- ADORA2B mediated anti-inflammatory cytokines production
|
- Caffeine
- Theophylline
- Mefloquine
- Lamotrigine
- Adenosine
- Dyphylline
- Pentoxifylline
- Enprofylline
- Oxtriphylline
- Theobromine
- Binodenoson
- Defibrotide
- Apadenoson
- Atl146e
- Regadenoson
- 4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol
- Doxofylline
- Istradefylline
- 8-chlorotheophylline
|
|
APH1A |
aph-1 homolog A, gamma-secretase subunit |
- Nuclear signaling by ERBB4
- Regulated proteolysis of p75NTR
- NRIF signals cell death from the nucleus
- Activated NOTCH1 Transmits Signal to the Nucleus
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- NOTCH2 Activation and Transmission of Signal to the Nucleus
- EPH-ephrin mediated repulsion of cells
- NOTCH3 Activation and Transmission of Signal to the Nucleus
- NOTCH4 Activation and Transmission of Signal to the Nucleus
- Noncanonical activation of NOTCH3
- Amyloid fiber formation
|
|
|
ARL1 |
ADP ribosylation factor like GTPase 1 |
- Retrograde transport at the Trans-Golgi-Network
|
|
|
ARL6IP6 |
ADP ribosylation factor like GTPase 6 interacting protein 6 |
|
|
|
ATP6V0A2 |
ATPase H+ transporting V0 subunit a2 |
- ROS and RNS production in phagocytes
- Insulin receptor recycling
- Transferrin endocytosis and recycling
- Ion channel transport
|
|
|
ATP6V0C |
ATPase H+ transporting V0 subunit c |
- ROS and RNS production in phagocytes
- Neutrophil degranulation
- Insulin receptor recycling
- Transferrin endocytosis and recycling
- Amino acids regulate mTORC1
- Ion channel transport
|
|
|
BCAP29 |
B cell receptor associated protein 29 |
|
|
|
BCAP31 |
B cell receptor associated protein 31 |
- Apoptotic cleavage of cellular proteins
- Apoptotic execution phase
- RHOA GTPase cycle
- Antigen Presentation: Folding, assembly and peptide loading of class I MHC
|
|
|
CADPS |
calcium dependent secretion activator |
|
- Calcium citrate
- Calcium Phosphate
- Calcium phosphate dihydrate
|
|
CADPS2 |
calcium dependent secretion activator 2 |
|
- Calcium citrate
- Calcium Phosphate
- Calcium phosphate dihydrate
|
|
CALM1 |
calmodulin 1 |
- CaMK IV-mediated phosphorylation of CREB
- CaMK IV-mediated phosphorylation of CREB
- Calmodulin induced events
- Cam-PDE 1 activation
- CaM pathway
- Platelet degranulation
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
- PKA activation
- DARPP-32 events
- Synthesis of IP3 and IP4 in the cytosol
- Calcineurin activates NFAT
- Calcineurin activates NFAT
- eNOS activation
- Transcriptional activation of mitochondrial biogenesis
- Inactivation, recovery and regulation of the phototransduction cascade
- Inactivation, recovery and regulation of the phototransduction cascade
- Stimuli-sensing channels
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- Ca2+ pathway
- Reduction of cytosolic Ca++ levels
- Sodium/Calcium exchangers
- Unblocking of NMDA receptors, glutamate binding and activation
- CREB1 phosphorylation through the activation of Adenylate Cyclase
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- Ras activation upon Ca2+ influx through NMDA receptor
- Smooth Muscle Contraction
- Smooth Muscle Contraction
- Activation of Ca-permeable Kainate Receptor
- Uptake and function of anthrax toxins
- VEGFR2 mediated vascular permeability
- VEGFR2 mediated cell proliferation
- Phase 0 - rapid depolarisation
- Ion homeostasis
- CLEC7A (Dectin-1) induces NFAT activation
- CLEC7A (Dectin-1) induces NFAT activation
- RHO GTPases activate IQGAPs
- RHO GTPases activate PAKs
- RHO GTPases activate PAKs
- RAF activation
- RAF/MAP kinase cascade
- Signaling by moderate kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Glycogen breakdown (glycogenolysis)
- Glycogen breakdown (glycogenolysis)
- Protein methylation
- Extra-nuclear estrogen signaling
- Loss of phosphorylation of MECP2 at T308
- Regulation of MECP2 expression and activity
- Ion transport by P-type ATPases
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Activation of RAC1 downstream of NMDARs
- Activation of RAC1 downstream of NMDARs
- Activation of AMPK downstream of NMDARs
- Long-term potentiation
- Long-term potentiation
- RAS processing
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated IL10 synthesis
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Chlorpromazine
- Cinchocaine
- Nicardipine
- Fluphenazine
- Isoflurane
- Trifluoperazine
- Loperamide
- Perphenazine
- Phenoxybenzamine
- Felodipine
- Melatonin
- Promethazine
- Pimozide
- Nifedipine
- Bepridil
- Calcium
- Aprindine
- Deacetoxyvinzolidine
- tert-butanol
- Trimethyllysine
- N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
- Prenylamine
- Flunarizine
- (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
- Myristic acid
- Calcium citrate
- Calcium citrate
- Calcium citrate
- Calcium Phosphate
- Calcium Phosphate
- Calcium Phosphate
- Calcium levulinate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
|
|
CALM3 |
calmodulin 3 |
- CaMK IV-mediated phosphorylation of CREB
- CaMK IV-mediated phosphorylation of CREB
- Calmodulin induced events
- Cam-PDE 1 activation
- CaM pathway
- Platelet degranulation
- Translocation of SLC2A4 (GLUT4) to the plasma membrane
- Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
- PKA activation
- DARPP-32 events
- Synthesis of IP3 and IP4 in the cytosol
- Calcineurin activates NFAT
- Calcineurin activates NFAT
- eNOS activation
- Transcriptional activation of mitochondrial biogenesis
- Inactivation, recovery and regulation of the phototransduction cascade
- Inactivation, recovery and regulation of the phototransduction cascade
- Stimuli-sensing channels
- FCERI mediated Ca+2 mobilization
- FCERI mediated Ca+2 mobilization
- Ca2+ pathway
- Reduction of cytosolic Ca++ levels
- Sodium/Calcium exchangers
- Unblocking of NMDA receptors, glutamate binding and activation
- CREB1 phosphorylation through the activation of Adenylate Cyclase
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
- Ras activation upon Ca2+ influx through NMDA receptor
- Smooth Muscle Contraction
- Smooth Muscle Contraction
- Activation of Ca-permeable Kainate Receptor
- Uptake and function of anthrax toxins
- VEGFR2 mediated vascular permeability
- VEGFR2 mediated cell proliferation
- Phase 0 - rapid depolarisation
- Ion homeostasis
- CLEC7A (Dectin-1) induces NFAT activation
- CLEC7A (Dectin-1) induces NFAT activation
- RHO GTPases activate IQGAPs
- RHO GTPases activate PAKs
- RHO GTPases activate PAKs
- RAF activation
- RAF/MAP kinase cascade
- Signaling by moderate kinase activity BRAF mutants
- Signaling by BRAF and RAF1 fusions
- Paradoxical activation of RAF signaling by kinase inactive BRAF
- Glycogen breakdown (glycogenolysis)
- Glycogen breakdown (glycogenolysis)
- Protein methylation
- Extra-nuclear estrogen signaling
- Loss of phosphorylation of MECP2 at T308
- Regulation of MECP2 expression and activity
- Ion transport by P-type ATPases
- Negative regulation of NMDA receptor-mediated neuronal transmission
- Activation of RAC1 downstream of NMDARs
- Activation of RAC1 downstream of NMDARs
- Activation of AMPK downstream of NMDARs
- Long-term potentiation
- Long-term potentiation
- RAS processing
- Signaling downstream of RAS mutants
- Signaling by RAF1 mutants
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated IL10 synthesis
- Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
|
- Chlorpromazine
- Cinchocaine
- Nicardipine
- Fluphenazine
- Isoflurane
- Trifluoperazine
- Loperamide
- Perphenazine
- Phenoxybenzamine
- Felodipine
- Melatonin
- Promethazine
- Pimozide
- Nifedipine
- Bepridil
- Calcium
- Aprindine
- Deacetoxyvinzolidine
- tert-butanol
- Trimethyllysine
- N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
- Prenylamine
- Flunarizine
- (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
- Myristic acid
- Calcium citrate
- Calcium citrate
- Calcium citrate
- Calcium Phosphate
- Calcium Phosphate
- Calcium Phosphate
- Calcium levulinate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
- Calcium phosphate dihydrate
|
|
CASP1 |
caspase 1 |
- NOD1/2 Signaling Pathway
- Interleukin-1 processing
- Pyroptosis
- TP53 Regulates Transcription of Caspase Activators and Caspases
- The NLRP3 inflammasome
- The AIM2 inflammasome
- The IPAF inflammasome
- Interleukin-37 signaling
- Purinergic signaling in leishmaniasis infection
|
- Acetylsalicylic acid
- Minocycline
- Pralnacasan
- LAX-101
- Emricasan
- VX-765
- 1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
- Z-Val-Ala-Asp fluoromethyl ketone
- 3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID
|
|
CCKBR |
cholecystokinin B receptor |
- Peptide ligand-binding receptors
- G alpha (q) signalling events
- Gastrin-CREB signalling pathway via PKC and MAPK
|
- Pentagastrin
- Cholecystokinin
|
|
CCNA2 |
cyclin A2 |
- Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1
- G0 and Early G1
- Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes
- Telomere Extension By Telomerase
- Cdc20:Phospho-APC/C mediated degradation of Cyclin A
- Regulation of APC/C activators between G1/S and early anaphase
- SCF(Skp2)-mediated degradation of p27/p21
- Senescence-Associated Secretory Phenotype (SASP)
- DNA Damage/Telomere Stress Induced Senescence
- Ub-specific processing proteases
- Processing of DNA double-strand break ends
- TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
- Regulation of TP53 Activity through Phosphorylation
- Regulation of TP53 Degradation
- G2 Phase
- Orc1 removal from chromatin
- CDK-mediated phosphorylation and removal of Cdc6
- Cyclin A/B1/B2 associated events during G2/M transition
- Cyclin A/B1/B2 associated events during G2/M transition
- p53-Dependent G1 DNA Damage Response
- Cyclin A:Cdk2-associated events at S phase entry
|
- 4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
- 6-O-Cyclohexylmethyl Guanine
- [4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine
- 4-(2,4-Dimethyl-1,3-thiazol-5-yl)-N-[4-(trifluoromethyl)phenyl]-2-pyrimidinamine
- 4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE
- N-(3-cyclopropyl-1H-pyrazol-5-yl)-2-(2-naphthyl)acetamide
- 2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE
- O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE
- (2S)-N-[(3E)-5-Cyclopropyl-3H-pyrazol-3-ylidene]-2-[4-(2-oxo-1-imidazolidinyl)phenyl]propanamide
- N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine
- 6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE
- 5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE
- 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE
- 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE
- 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE
- 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID
- N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE
- 4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE
- 1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID
- 4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine
- 4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine
- HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM
- 4-Methyl-5-[(2Z)-2-{[4-(4-morpholinyl)phenyl]imino}-2,5-dihydro-4-pyrimidinyl]-1,3-thiazol-2-amine
- 6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE
- 4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE
- 3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE
- (2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol
- 3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL
- 1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid
- (2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol
- 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE
- 4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE
- Variolin B
|
|
CD3E |
CD3e molecule |
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Downstream TCR signaling
- Phosphorylation of CD3 and TCR zeta chains
- Translocation of ZAP-70 to Immunological synapse
- Generation of second messenger molecules
- PD-1 signaling
|
|
|
CD3G |
CD3g molecule |
- Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
- Downstream TCR signaling
- Phosphorylation of CD3 and TCR zeta chains
- Translocation of ZAP-70 to Immunological synapse
- Generation of second messenger molecules
- FCGR activation
- FCGR activation
- Regulation of actin dynamics for phagocytic cup formation
- Role of phospholipids in phagocytosis
- PD-1 signaling
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- FCGR3A-mediated IL10 synthesis
- FCGR3A-mediated phagocytosis
|
|
|
CERS1 |
ceramide synthase 1 |
- Sphingolipid de novo biosynthesis
|
|
|
CERS2 |
ceramide synthase 2 |
- Sphingolipid de novo biosynthesis
|
|
|
CHPT1 |
choline phosphotransferase 1 |
|
|
|
CLDND1 |
claudin domain containing 1 |
|
|
|
CLIC6 |
chloride intracellular channel 6 |
|
|
|
CRELD1 |
cysteine rich with EGF like domains 1 |
|
|
|
E2F6 |
E2F transcription factor 6 |
- G1/S-Specific Transcription
- Transcriptional Regulation by E2F6
|
|
|
EPB41 |
erythrocyte membrane protein band 4.1 |
- Neurexins and neuroligins
|
|
|
EPB41L1 |
erythrocyte membrane protein band 4.1 like 1 |
- Trafficking of AMPA receptors
- Neurexins and neuroligins
- Sensory processing of sound by inner hair cells of the cochlea
- Sensory processing of sound by outer hair cells of the cochlea
|
|
|
FLNA |
filamin A |
- Platelet degranulation
- GP1b-IX-V activation signalling
- Cell-extracellular matrix interactions
- RHO GTPases activate PAKs
- OAS antiviral response
|
|
|
GABBR1 |
gamma-aminobutyric acid type B receptor subunit 1 |
- Activation of G protein gated Potassium channels
- G alpha (i) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
- GABA B receptor activation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Baclofen
- Progabide
- Taurine
- gamma-Aminobutyric acid
- SGS-742
- Tezampanel
- Arbaclofen
- Arbaclofen Placarbil
|
|
GABBR2 |
gamma-aminobutyric acid type B receptor subunit 2 |
- Activation of G protein gated Potassium channels
- G alpha (i) signalling events
- Class C/3 (Metabotropic glutamate/pheromone receptors)
- GABA B receptor activation
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Baclofen
- gamma-Aminobutyric acid
- SGS-742
- Arbaclofen
- Arbaclofen Placarbil
|
|
GDPD2 |
glycerophosphodiester phosphodiesterase domain containing 2 |
|
|
|
GHITM |
growth hormone inducible transmembrane protein |
|
|
|
GIPC1 |
GIPC PDZ domain containing family member 1 |
|
|
|
GNAI2 |
G protein subunit alpha i2 |
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- ADP signalling through P2Y purinoceptor 12
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Regulation of insulin secretion
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
|
|
GNAI3 |
G protein subunit alpha i3 |
- Adenylate cyclase inhibitory pathway
- Adenylate cyclase inhibitory pathway
- ADP signalling through P2Y purinoceptor 12
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
|
|
|
GNAZ |
G protein subunit alpha z |
- G alpha (s) signalling events
- G alpha (i) signalling events
- G alpha (z) signalling events
- G alpha (z) signalling events
- ADORA2B mediated anti-inflammatory cytokines production
|
|
|
GNB5 |
G protein subunit beta 5 |
- Activation of G protein gated Potassium channels
- G-protein activation
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- Glucagon-like Peptide-1 (GLP1) regulates insulin secretion
- ADP signalling through P2Y purinoceptor 12
- G beta:gamma signalling through PI3Kgamma
- Prostacyclin signalling through prostacyclin receptor
- Prostacyclin signalling through prostacyclin receptor
- Adrenaline,noradrenaline inhibits insulin secretion
- Adrenaline,noradrenaline inhibits insulin secretion
- Ca2+ pathway
- Ca2+ pathway
- G alpha (q) signalling events
- G alpha (12/13) signalling events
- G beta:gamma signalling through PLC beta
- G alpha (s) signalling events
- ADP signalling through P2Y purinoceptor 1
- ADP signalling through P2Y purinoceptor 1
- G alpha (i) signalling events
- G alpha (z) signalling events
- Glucagon-type ligand receptors
- Thromboxane signalling through TP receptor
- Vasopressin regulates renal water homeostasis via Aquaporins
- Thrombin signalling through proteinase activated receptors (PARs)
- Thrombin signalling through proteinase activated receptors (PARs)
- Presynaptic function of Kainate receptors
- Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
- G beta:gamma signalling through BTK
- G beta:gamma signalling through CDC42
- Extra-nuclear estrogen signaling
- ADORA2B mediated anti-inflammatory cytokines production
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
|
|
GPC6 |
glypican 6 |
- A tetrasaccharide linker sequence is required for GAG synthesis
- HS-GAG biosynthesis
- HS-GAG biosynthesis
- HS-GAG degradation
- Defective B4GALT7 causes EDS, progeroid type
- Defective B3GAT3 causes JDSSDHD
- Defective EXT2 causes exostoses 2
- Defective EXT1 causes exostoses 1, TRPS2 and CHDS
- Defective B3GALT6 causes EDSP2 and SEMDJL1
- Retinoid metabolism and transport
|
|
|
GPR137 |
G protein-coupled receptor 137 |
|
|
|
GPR37 |
G protein-coupled receptor 37 |
- Peptide ligand-binding receptors
- G alpha (i) signalling events
|
|
|
GRIA2 |
glutamate ionotropic receptor AMPA type subunit 2 |
- Activation of AMPA receptors
- Trafficking of GluR2-containing AMPA receptors
- Unblocking of NMDA receptors, glutamate binding and activation
- Unblocking of NMDA receptors, glutamate binding and activation
- MECP2 regulates neuronal receptors and channels
- Long-term potentiation
|
- Glutamic acid
- Butabarbital
- Butalbital
- Talbutal
- Pentobarbital
- Secobarbital
- Metharbital
- Thiopental
- Primidone
- Methylphenobarbital
- Ethanol
- Phenobarbital
- Quinidine barbiturate
- Amobarbital
- Aprobarbital
- Butobarbital
- Heptabarbital
- Hexobarbital
- Barbital
- Dihydro-2-thioxo-5-((5-(2-(trifluoromethyl)phenyl)-2-furanyl)methyl)-4,6(1H,5H)-pyrimidinedione
- (S)-DES-ME-AMPA
- (S)-AMPA
- 2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid
- Iodo-Willardiine
- Fluoro-Willardiine
- Quisqualic acid
- (S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid
- (2S)-2-Ammonio-3-[5-(2-methyl-2-propanyl)-3-oxido-1,2-oxazol-4-yl]propanoate
- FG-9041
- Bromo-Willardiine
- Willardiine
- 2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid
- Aniracetam
- THIO-ATPA
- Talampanel
- CX-717
- N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide
- 2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE
- (3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide
- (3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide
- (3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide
- Fluciclovine (18F)
|
|
GRINA |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
|
|
|
HRH3 |
histamine receptor H3 |
|
- Olopatadine
- Aripiprazole
- OBE101
- Histamine
- Betahistine
- Pitolisant
|
|
IL10RA |
interleukin 10 receptor subunit alpha |
|
|
|
INPPL1 |
inositol polyphosphate phosphatase like 1 |
- Synthesis of PIPs at the plasma membrane
- Synthesis of IP3 and IP4 in the cytosol
- Interleukin receptor SHC signaling
|
|
|
KBTBD6 |
kelch repeat and BTB domain containing 6 |
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
KBTBD7 |
kelch repeat and BTB domain containing 7 |
- Regulation of RAS by GAPs
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
KCNJ6 |
potassium inwardly rectifying channel subfamily J member 6 |
- Activation of G protein gated Potassium channels
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
- Ethanol
- Halothane
- Ifenprodil
- Isavuconazole
|
|
KCNJ9 |
potassium inwardly rectifying channel subfamily J member 9 |
- Activation of G protein gated Potassium channels
- Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
|
|
LPAR1 |
lysophosphatidic acid receptor 1 |
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosphingolipid and LPA receptors
|
|
|
NCS1 |
neuronal calcium sensor 1 |
|
- Calcium citrate
- Calcium Phosphate
- Calcium phosphate dihydrate
|
|
NDUFV1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
- Respiratory electron transport
- Complex I biogenesis
|
|
|
NEFM |
neurofilament medium chain |
|
|
|
NQO2 |
N-ribosyldihydronicotinamide:quinone reductase 2 |
- Phase I - Functionalization of compounds
|
- NADH
- Menadione
- Melatonin
- Primaquine
- Resveratrol
- Flavin adenine dinucleotide
- 10-Propargyl-5,8-Dideazafolic Acid
- Quercetin
- Tretazicar
- (3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione
- N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide
- 5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one
- Casimiroin
|
|
NSF |
N-ethylmaleimide sensitive factor, vesicle fusing ATPase |
- COPII-mediated vesicle transport
- Trafficking of GluR2-containing AMPA receptors
- COPI-mediated anterograde transport
- COPI-dependent Golgi-to-ER retrograde traffic
- Intra-Golgi traffic
- Retrograde transport at the Trans-Golgi-Network
|
- 1-Ethyl-Pyrrolidine-2,5-Dione
|
|
OPRM1 |
opioid receptor mu 1 |
- Opioid Signalling
- G-protein activation
- Peptide ligand-binding receptors
- G alpha (i) signalling events
- Interleukin-4 and Interleukin-13 signaling
- MECP2 regulates neuronal receptors and channels
|
- Tramadol
- Morphine
- Codeine
- Amitriptyline
- Hydromorphone
- Methadone
- Meperidine
- Oxycodone
- Levallorphan
- Dextromethorphan
- Butorphanol
- Dextropropoxyphene
- Pentazocine
- Naltrexone
- Sufentanil
- Alfentanil
- Fentanyl
- Loperamide
- Nalbuphine
- Levorphanol
- Remifentanil
- Ondansetron
- Anileridine
- Buprenorphine
- Hydrocodone
- Diphenoxylate
- Naloxone
- Oxymorphone
- Dezocine
- Ketamine
- Levacetylmethadol
- Aripiprazole
- Methadyl acetate
- 3-Methylthiofentanyl
- Dimethylthiambutene
- Diamorphine
- Ethylmorphine
- Etorphine
- Carfentanil
- Diprenorphine
- Dihydromorphine
- 3-Methylfentanyl
- V1003
- Epicept NP-1
- LI-301
- Tapentadol
- Nalmefene
- Alvimopan
- Morphine glucuronide
- Ketobemidone
- Methylnaltrexone
- Naloxegol
- Cannabidiol
- Trimebutine
- Butyrfentanyl
- Pholcodine
- Eluxadoline
- Tianeptine
- Opium
- Pentoxyverine
- Naldemedine
- Metenkefalin
- Medical Cannabis
- Nabiximols
- Loxicodegol
- Oliceridine
|
|
PAQR6 |
progestin and adipoQ receptor family member 6 |
|
|
|
PAWR |
pro-apoptotic WT1 regulator |
|
|
|
PIGG |
phosphatidylinositol glycan anchor biosynthesis class G |
- Synthesis of glycosylphosphatidylinositol (GPI)
|
|
|
PLLP |
plasmolipin |
|
|
|
PLPPR3 |
phospholipid phosphatase related 3 |
- Lysosphingolipid and LPA receptors
|
|
|
PPP1R9B |
protein phosphatase 1 regulatory subunit 9B |
|
|
|
PSG7 |
pregnancy specific beta-1-glycoprotein 7 |
- Cell surface interactions at the vascular wall
|
|
|
RBM22 |
RNA binding motif protein 22 |
- mRNA Splicing - Major Pathway
|
|
|
RHBDD2 |
rhomboid domain containing 2 |
|
|
|
RTN1 |
reticulon 1 |
|
|
|
RTN3 |
reticulon 3 |
- Synaptic adhesion-like molecules
|
|
|
RTN4 |
reticulon 4 |
- Axonal growth inhibition (RHOA activation)
|
|
|
SERINC3 |
serine incorporator 3 |
|
|
|
SGSH |
N-sulfoglucosamine sulfohydrolase |
- HS-GAG degradation
- MPS IIIA - Sanfilippo syndrome A
|
|
|
SLC15A4 |
solute carrier family 15 member 4 |
- Proton/oligopeptide cotransporters
- Neutrophil degranulation
|
|
|
SLC22A17 |
solute carrier family 22 member 17 |
- Iron uptake and transport
- Iron uptake and transport
|
|
|
SLC35B1 |
solute carrier family 35 member B1 |
|
|
|
SLC4A3 |
solute carrier family 4 member 3 |
|
|
|
SLC6A1 |
solute carrier family 6 member 1 |
- Na+/Cl- dependent neurotransmitter transporters
- Reuptake of GABA
|
|
|
SLC6A3 |
solute carrier family 6 member 3 |
- Dopamine clearance from the synaptic cleft
- Na+/Cl- dependent neurotransmitter transporters
- Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
- Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS)
|
- Amphetamine
- Phentermine
- Benzatropine
- Venlafaxine
- Loxapine
- Methylphenidate
- Meperidine
- Imipramine
- Duloxetine
- Amoxapine
- Mazindol
- Procaine
- Trimipramine
- Modafinil
- Phenmetrazine
- Pseudoephedrine
- Benzphetamine
- Cocaine
- Diethylpropion
- Dopamine
- Sertraline
- Sibutramine
- Chlorpheniramine
- Diphenylpyraline
- Nefazodone
- Bupropion
- Chloroprocaine
- Escitalopram
- Aripiprazole
- Ephedra sinica root
- MMDA
- Midomafetamine
- Fencamfamin
- 4-Methoxyamphetamine
- Dextroamphetamine
- Metamfetamine
- Vanoxerine
- Nomifensine
- Altropane
- Mianserin
- Tesofensine
- Trodusquemine
- Armodafinil
- Desvenlafaxine
- Dexmethylphenidate
- Dasotraline
- Solriamfetol
|
|
SMIM7 |
small integral membrane protein 7 |
|
|
|
SPP1 |
secreted phosphoprotein 1 |
- Degradation of the extracellular matrix
- Signaling by PDGF
- Integrin cell surface interactions
- Integrin cell surface interactions
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- RUNX3 Regulates Immune Response and Cell Migration
- Post-translational protein phosphorylation
|
|
|
SSTR2 |
somatostatin receptor 2 |
- Peptide ligand-binding receptors
- G alpha (i) signalling events
|
- Vapreotide
- Pasireotide
- Lanreotide
- Somatostatin
- Dotatate gallium Ga-68
- Lutetium Lu 177 dotatate
- Edotreotide gallium Ga-68
- Copper oxodotreotide Cu-64
|
|
SSTR5 |
somatostatin receptor 5 |
- Peptide ligand-binding receptors
- G alpha (i) signalling events
|
- Vapreotide
- Pasireotide
- Lanreotide
- Somatostatin
- Lutetium Lu 177 dotatate
- Edotreotide gallium Ga-68
|
|
SYNGR2 |
synaptogyrin 2 |
|
|
|
TF |
transferrin |
- Platelet degranulation
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- Post-translational protein phosphorylation
- Iron uptake and transport
- Transferrin endocytosis and recycling
|
- Cisplatin
- Isoflurophate
- Aluminium
- Iron
- Zinc
- Manganese
- Copper
- Dichlorvos
- Zinc acetate
- Ferrous gluconate
- Ferrous succinate
- Ferrous ascorbate
- Ferrous fumarate
- Ferrous glycine sulfate
- Aluminium phosphate
- Aluminum acetate
- Zinc chloride
- Zinc sulfate, unspecified form
|
|
TMEFF2 |
transmembrane protein with EGF like and two follistatin like domains 2 |
|
|
|
TMEM101 |
transmembrane protein 101 |
|
|
|
TMEM11 |
transmembrane protein 11 |
|
|
|
TMEM63A |
transmembrane protein 63A |
|
|
|
TRAM1 |
translocation associated membrane protein 1 |
- SRP-dependent cotranslational protein targeting to membrane
|
|
|
TRPC4 |
transient receptor potential cation channel subfamily C member 4 |
- TRP channels
- Role of second messengers in netrin-1 signaling
|
|
|
TRPC5 |
transient receptor potential cation channel subfamily C member 5 |
- TRP channels
- Role of second messengers in netrin-1 signaling
|
|
|
TSPAN3 |
tetraspanin 3 |
|
|
|
TSPAN7 |
tetraspanin 7 |
- Cell surface interactions at the vascular wall
- Trafficking of GluR2-containing AMPA receptors
|
|
|
TTYH1 |
tweety family member 1 |
|
|
|
VWA5A |
von Willebrand factor A domain containing 5A |
|
|
|
WFS1 |
wolframin ER transmembrane glycoprotein |
- XBP1(S) activates chaperone genes
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- Post-translational protein phosphorylation
|
|
|
WLS |
Wnt ligand secretion mediator |
- WNT ligand biogenesis and trafficking
|
|
|
YIPF3 |
Yip1 domain family member 3 |
|
|
|
ZDHHC4 |
zinc finger DHHC-type palmitoyltransferase 4 |
|
|
|